When did this incident occur?

The incident is recorded as occurring on December 16, 2025 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.

Incident · Regulatory action

FDA clears CMR Surgical Versius Plus robotic surgical system via 510(k) for cholecystectomy

The FDA cleared CMR Surgical's Versius Plus minimally invasive robotic surgical system via the 510(k) pathway (K252111), with a decision date of December 16, 2025. The system is indicated for gallbladder removal (cholecystectomy) and features a modular design for portability between hospital departments. CMR plans to begin US commercialization in 2026.

Occurred 2025-12-16 · CMR Surgical · Investigated by FDA

How to read this record

Incident records on DEPLOY are compiled from public sources (regulatory filings, news reports, and operator disclosures) and reflect what has been reported and tracked to date. They are not legal findings, determinations of fault, or safety ratings, and may be updated as new information is verified. See the sources below for the underlying references.

Track FDA clears CMR Surgical Versius Plus robotic surgical system via 510(k) for cholecystectomy

Machine-readable surfaces

Markdown mirror: /incidents/fda-cmr-versius-plus-510k-dec2025.md
JSON-LD: embedded in this page’s head
REST API: /v1/incidents/7c96ee5c-2bb2-4613-9195-d3b7b2bae795
Data documentation: /data
Query this programmatically: Deploy MCP

Sources (1)

FDA · https://www.accessdata.fda.gov/cdrh_docs/pdf25/K252111.pdf · 2025-12-16

Status history

Active · 2026-07-23 · agent:recon

Common questions

What happened in FDA clears CMR Surgical Versius Plus robotic surgical system via 510(k) for cholecystectomy?: The FDA cleared CMR Surgical's Versius Plus minimally invasive robotic surgical system via the 510(k) pathway (K252111), with a decision date of December 16, 2025. The system is indicated for gallbladder removal (cholecystectomy) and features a modular design for portability between hospital departments. CMR plans to begin US commercialization in 2026.
When did this incident occur?: The incident is recorded as occurring on December 16, 2025 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.
Who was involved in FDA clears CMR Surgical Versius Plus robotic surgical system via 510(k) for cholecystectomy?: The incident is recorded as involving CMR Surgical on the DEPLOY registry. No specific robot model is linked to this incident in the registry.
Has anyone responded to FDA clears CMR Surgical Versius Plus robotic surgical system via 510(k) for cholecystectomy?: No responses to this incident are recorded on the DEPLOY registry. Operators, manufacturers, or affected parties can submit responses to the editorial team; absence is not a guarantee no response was issued.
What is the current status of FDA clears CMR Surgical Versius Plus robotic surgical system via 510(k) for cholecystectomy?: This incident is an active record on the DEPLOY registry; no retraction or correction has been issued.

Methodology: Unreviewed · 1 source (1 primary) · last reviewed 2026-07-23

Verification posture

Unreviewed

Low confidence

Review state

Stable

Last reviewed 2026-07-23

Sources by quality tier

1: primary-fda-database; FDA database

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Deploy Watch

Track this incident.

We notify you when the regulator updates the record, the remedy status changes, or a related incident surfaces.

Canonical ID 7c96ee5c-2bb2-4613-9195-d3b7b2bae795